RE: MAb in Covid-19 trials30 Sep 2020 07:24
From the linked article 'Patients received either placebo, 2.4 grams of REGN-COV2, or 8 grams of REGN-COV2. (The antibody ****tail is delivered intravenously.)'
That's another IV administered product, we have the crown jewel, in that it can be inhaled thus ease of administering. This will go directly to the lungs, so possibly requiring a smaller dose, leading to less toxicity.
Hang in there, there is also, so much more in the pipeline. This is a £bn company before the demerger, how many £bn's in 5/12 months?
BB